Pharmather
Published September 6, 2026
Investor Info and Press Releases - PharmaTher (OTCQB: PHRRF) (CSE: PHRM)
7/21/2026. PharmaTher Enters into Collaboration Agreement for KetaMist® to Advance Needle-Free Ketamine Treatment Toward FDA Approval · Read More. 7.
Read the full story at Pharmather
Surfaced by 2 Google Alerts
- Ketamine
- Psychedelics